ClinicalTrials.gov
public full text
Public Domain
An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
This study conducted to more fully evaluate the way that carbidopa/levodopa and entacapone may work in the brain. This research study uses \[123I\]-IBZM and dynamic SPECT imaging to determine the amount and the duration of dopamine release from specific regions in the brain after treatment with either the combination of carbidopa/levodopa or the combination of carbidopa/levodopa/entacapone.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's#1102541
- A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.#850787
- Rebalancing the Serotonergic System in Cocaine Dependence#1261496
- Investigating Two rTMS Strategies to Treat Cannabis Use Disorder#1195624
- Modulation of Cognitive Flexibility by Tyrosine Depletion and Transcranial Direct Current Stimulation#1074136
Record · ID 1422046
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive